The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects.
We have previously reported that the hypothalamo-pituitary-adrenal response to insulin-induced hypoglycaemia is normal while the cortisol release to pituitary stimulation by corticotrophin releasing factor (CRF-41) is reduced in obesity. Impaired growth hormone (GH) secretion is also found in obesit...
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Sprache: | English |
| Veröffentlicht: |
1989
|
| _version_ | 1826296582828457984 |
|---|---|
| author | Stafford, P Kopelman, P Davidson, K McLoughlin, L White, A Rees, L Besser, G Coy, D Grossman, A |
| author_facet | Stafford, P Kopelman, P Davidson, K McLoughlin, L White, A Rees, L Besser, G Coy, D Grossman, A |
| author_sort | Stafford, P |
| collection | OXFORD |
| description | We have previously reported that the hypothalamo-pituitary-adrenal response to insulin-induced hypoglycaemia is normal while the cortisol release to pituitary stimulation by corticotrophin releasing factor (CRF-41) is reduced in obesity. Impaired growth hormone (GH) secretion is also found in obesity which may result from altered central levels of somatostatin (SMS). We have investigated, by giving a simultaneous infusion of SMS to six volunteer normal weight men during a CRF test, whether it is possible for SMS to modify pituitary-adrenal function. Each subject received intravenous CRF-41 (0.5 micrograms/kg) on two occasions during an infusion of isotonic saline or SMS (4 micrograms/min) in a randomized double-blind study. Plasma GH, cortisol, ACTH and SMS were measured. Three subjects demonstrated GH peaks during saline infusion but no peaks were seen in any subject during SMS infusion. No significant difference was found between peak cortisol responses during saline or SMS infusion (SMS cortisol 443 +/- 61 nmol/l, saline cortisol 485 +/- 52 nmol/l); neither was there any difference in the ACTH responses. We conclude that SMS does not alter the pituitary response to CRF in normal weight men and is thus less likely to be responsible for the altered pituitary-adrenal function seen in obesity. Further studies of alternative mechanisms are required to explain the cause of this abnormality. |
| first_indexed | 2024-03-07T04:18:34Z |
| format | Journal article |
| id | oxford-uuid:ca3e322e-292c-49ea-8882-bbf91577439f |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:18:34Z |
| publishDate | 1989 |
| record_format | dspace |
| spelling | oxford-uuid:ca3e322e-292c-49ea-8882-bbf91577439f2022-03-27T07:05:58ZThe pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ca3e322e-292c-49ea-8882-bbf91577439fEnglishSymplectic Elements at Oxford1989Stafford, PKopelman, PDavidson, KMcLoughlin, LWhite, ARees, LBesser, GCoy, DGrossman, AWe have previously reported that the hypothalamo-pituitary-adrenal response to insulin-induced hypoglycaemia is normal while the cortisol release to pituitary stimulation by corticotrophin releasing factor (CRF-41) is reduced in obesity. Impaired growth hormone (GH) secretion is also found in obesity which may result from altered central levels of somatostatin (SMS). We have investigated, by giving a simultaneous infusion of SMS to six volunteer normal weight men during a CRF test, whether it is possible for SMS to modify pituitary-adrenal function. Each subject received intravenous CRF-41 (0.5 micrograms/kg) on two occasions during an infusion of isotonic saline or SMS (4 micrograms/min) in a randomized double-blind study. Plasma GH, cortisol, ACTH and SMS were measured. Three subjects demonstrated GH peaks during saline infusion but no peaks were seen in any subject during SMS infusion. No significant difference was found between peak cortisol responses during saline or SMS infusion (SMS cortisol 443 +/- 61 nmol/l, saline cortisol 485 +/- 52 nmol/l); neither was there any difference in the ACTH responses. We conclude that SMS does not alter the pituitary response to CRF in normal weight men and is thus less likely to be responsible for the altered pituitary-adrenal function seen in obesity. Further studies of alternative mechanisms are required to explain the cause of this abnormality. |
| spellingShingle | Stafford, P Kopelman, P Davidson, K McLoughlin, L White, A Rees, L Besser, G Coy, D Grossman, A The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects. |
| title | The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects. |
| title_full | The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects. |
| title_fullStr | The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects. |
| title_full_unstemmed | The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects. |
| title_short | The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects. |
| title_sort | pituitary adrenal response to crf 41 is unaltered by intravenous somatostatin in normal subjects |
| work_keys_str_mv | AT staffordp thepituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT kopelmanp thepituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT davidsonk thepituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT mcloughlinl thepituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT whitea thepituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT reesl thepituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT besserg thepituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT coyd thepituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT grossmana thepituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT staffordp pituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT kopelmanp pituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT davidsonk pituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT mcloughlinl pituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT whitea pituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT reesl pituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT besserg pituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT coyd pituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects AT grossmana pituitaryadrenalresponsetocrf41isunalteredbyintravenoussomatostatininnormalsubjects |